Safety Profile and Metabolic Effects of 14 Days of Treatment with DIO-902: Results of a Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial in Patients with Type 2 Diabetes Mellitus
Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Clinical Therapeutics
Authors: S SCHWARTZ, M RENDELL, A AHMANN, A THOMAS, C ARAUZPACHECO, B WELLES
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2114001870
